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Abstract. We present the Spinal Cord Injury Ontology (SCIO), which has the goal
to support the representation of pre-clinical studies in the domain of spinal cord in-
jury (SCI) therapies. The ontology is developed in the context of the PSINK project,
as part of an information extraction lifecycle to populate a database with compre-
hensive knowledge about pre-clinical studies published in the SCI literature. This
database enables domain experts to explore and access all relevant knowledge that
is available as a basis to support clinical decision-making and translation of pre-
clinical evidence into clinical practice. Here, we discuss the methodology underly-
ing the development of SCIO and the main design choices made throughout. We
also present a web application that relies on SCIO to organize pre-clinical know-
ledge and present it to domain experts for exploration purposes. In particular, the
application enables experts to get relevant answers and insights on the outcomes
of different therapies in pre-clinical studies and how their effectiveness varies de-
pending on core parameters such as injury type, dosage, time of application, or
investigation method applied, among others.
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1. Introduction
On every single day, thousands of new scientific publications are uploaded to PubMed1,
the standard repository for biomedical literature. The subset of literature that is rele-
vant for spinal cord injury treatment comprises more than 130,000 publications currently
1https://www.ncbi.nlm.nih.gov/pubmed
available in PubMed, among them approx. 18,000 pre-clinical SCI studies.2 It is impos-
sible for any research group, let alone individual researchers, to keep up with the amount
of medical knowledge published in their specific area. Yet, taking decisions in the interest
of promoting the state of the art or translating the available evidence from pre-clinical or
clinical studies into therapeutic concepts requires knowledge of all, or at least the most
important studies available. Meta-studies or systematic reviews obviously can help in this
respect, as they provide an overview of the most important results in the limited number
of papers included in such a meta-analysis. However, the creation of systematic reviews
is time-consuming. Thus, by the publication time of the review, some of the reviewed
results may already be outdated.
The goal of the PSINK project3 is to develop an information extraction workflow for
automatically gathering the main parameters of pre-clinical studies and use them to pop-
ulate a database that supports the exploration of the entirety of available pre-clinical ev-
idence. In PSINK, we are particularly concerned with aggregating available pre-clinical
evidence to support decision-making on which therapies might be prospective candi-
dates to develop a successful therapy to cure spinal cord injuries in human patients, thus
fostering the translation of pre-clinical therapeutic concepts into clinical practice.
For this purpose, the presented ontology supports the formalization of the structure,
parameters and results of a pre-clinical study. While the ontology has been designed with
the purpose of capturing pre-clinical studies in the spinal cord injury domain, its core can
be used to represent pre-clinical (and, partially, clinical) trials in other medical domains
as well. In this paper, we present the design of the ontology, the top-level structure and
which ontologies have been reused. We further describe our efforts to align SCIO with
other existing vocabularies. As a proof of concept, we present a web application that
has been developed based on the ontology and enables experts to explore the available
evidence.
2. Ontology Design
The Spinal Cord Injury Ontology has been designed following the methodology devel-
oped in the On-To-Knowledge project [1] and described by Sure et al. [2]. Domain ex-
perts in the field of spinal cord injury with substantial experience in performing pre-
clinical studies have been involved in all steps of the process.
The methodology comprises the four steps (i) Kick-off (definition of competency
questions that the ontology is expected to answer); (ii) Refinement (implementation in
the Web Ontology language using Protégé); (iii) Evaluation with respect to the com-
petency questions defined in the kick-off phase; (iv) Application and Evolution. In the
latter phase, the ontology has been used to automatically derive an annotation scheme
to be used to annotate a number of articles that the information extraction system can
be trained on. Moreover, the ontology has been used as the conceptual backbone for de-
veloping a web application that supports the exploration of the available evidence (cf.
Section 3).
Figure 1. Schematic overview of the basic logic in SCI pre-clinical experiments.
2.1. Scope and Competency Questions
SCIO has been designed to mirror the standard workflow and basic configuration of a
pre-clinical study in the SCI domain: An animal model is selected and groups of animals
are defined which receive a certain type of injury and a treatment or no treatment, before
being examined for recovery. A schematic overview of this fundamental structure in SCI
pre-clinical experiments is shown in Figure 1. Even if multiple experimental groups are
compared to each other, the direct comparison and statistical analysis is based on two
groups with a defined setting of animals, experimental spinal cord injury and treatment.
In the example depicted in Figure 1, the two groups differ in treatment type. This could,
e.g., be subcutaneous application of a drug vs. application of the buffer as control.
The investigation method can be a histological analysis of the spinal cord tissue, a
molecular analysis or a functional/behavioural test (e.g., a horizontal ladder walking test
[3]), all of which are included in SCIO. The result of a test is either a between-group
difference of an investigated effect, e.g., the number of regenerating axons, or no change.
In the kick-off phase, the design team has defined a number of exemplary compe-
tency questions that the ontology should be able to answer:
(1) Which treatments yielded positive results in different animal models?
(2) Which treatments yielded positive results in functional as well as in non-
functional tests?
(3) Which treatments show positive results only in partial lesions but not in com-
plete lesions?
(4) Which treatments show a functional effect for thoracic as well as cervical le-
sions?
(5) In which lesion models being tested in male rats or mice have no negative effects
of erythropoietin been observed so far?
(6) After how many weeks can functional improvements of severe thoracic contu-
sions be expected?
(7) Which investigation methods reveal the earliest differences in functional or non-
functional tests between treatment and control groups?
2Results from querying PubMed for spinal cord injury and traumatic brain injury, as of September 13, 2017.
3http://www.psink.de
Figure 2. Ontological architecture of the main classes in SCIO.
2.2. Main Classes and Properties
Figure 2 shows the relations between the top-level classes in SCIO: Publication, Exper-
iment, Result, Observation, InvestigationMethod, ExperimentalGroup, OrganismModel,
Injury, and Treatment. The relations between these classes are as follows: Each Publica-
tion describes one or more experiments. Each Experiment consists of one or more results.
Each Result is related to exactly one InvestigationMethod, one TargetGroup (typically
the treated group), and a ReferenceGroup (e.g., a control group). A Result consists of a
number of Observations that are specific for one of the investigated experimental groups.
An ExperimentalGroup is defined by exactly one AnimalModel, one InjuryModel and
one Treatment. Overall, SCIO contains more than 500 manually added classes and 80
properties (data type and object type properties). We describe these classes in more detail
below, giving specific examples of RDF code that model a complete study.
Publication: Each publication is described by the meta-data associated with the re-
spective paper. This includes a unique identifier (e.g., PubMed ID) to ensure provenance
tracking, a list of authors, the year of publication etc. A publication describes one or
more experiments, each of which is related to one or more results. The RDF code4 in
Figure 3 shows an example.
Result: A result describes the outcome of a test within a specific setting, based on a
comparison of a reference group to a target group (cf. ExperimentalGroup). The setting is
mainly determined by an investigation method (cf. InvestigationMethod) and a statistical
4All examples in this paper are given in RDF Turtle format, using @prefix scio:
<http://psink.de/scio/> as a prefix referring to the SCIO namespace.
<scio:data/Publication_8>
a <scio:Publication> ;
<scio:describes>
<scio:data/Experiment_8> ;
<scio:hasAuthor>
<scio:data/Person_8> ;
<scio:hasPublicationYear>
"2009" ;
<scio:hasPubmedID>
"19372269" .
Figure 3. RDF excerpt describing a Publication instance.
<scio:data/Result_526>
a <scio:Result> ;
<scio:hasInvestigationMethod>
<scio:data/BBBTest_10> ;
<scio:hasJudgement>
<scio:Positive> ;
<scio:hasObservation>
<scio:data/Observation_1052> ,
<scio:data/Observation_1053> ;
<scio:hasReferenceGroup>
<scio:data/DefinedExperimentalGroup_1052> ;
<scio:hasStatisticalTest>
<scio:data/StatisticalTest_0> ;
<scio:hasTargetGroup>
<scio:data/DefinedExperimentalGroup_1053> ;
<scio:hasTrend>
<scio:data/Decrease_230> .
Figure 4. RDF excerpt describing a Result instance.
test. The subjective interpretation of the result is modelled via the (nominal) class Judge-
ment. Each result contains arbitrary observations supporting the author’s judgement. The
statistical observations describe the measurable Trend of the investigation method based
on the used statistical test (e.g., t-test).5 The RDF code in Figure 4 shows a result ob-
tained using a BBBTest as investigation method which yields two observations (one for
each experimental group), and for which a positive judgement can be derived based on
one statistical test. The Trend ‘Decrease’ represents the fact that the observed score of
the BBB test [4] is lower in the target group than in the reference group.
Observation: An observation represents a quantitative or qualitative measurement con-
ducted for a specific ExperimentalGroup (reference or target). Being related to a particu-
lar timepoint, each Observation is modelled as a Perdurant or Ocurrent. The observation
may store numeric values (e.g., a BBB score within a locomotor test) or non-numeric
values in case of vague descriptions such as “higher, weaker, better. . . ”. Figure 5 shows
5Note that a decreasing trend does not strictly imply a negative judgement, as the trend is an objective obser-
vation, whereas the judgement is a subjective opinion based on the investigation method and other variables.
<scio:data/Observation_1053>
a <scio:Observation> ;
<scio:belongsTo>
<scio:data/DefinedExperimentalGroup_1053> ;
<scio:hasNumericValue>
"12,5" ;
<scio:hasTemporalInterval>
<scio:data/TemporalInterval_526> .
Figure 5. RDF excerpt describing an Observation instance.
<scio:data/DefinedExperimentalGroup_99>
a <scio:DefinedExperimentalGroup> ;
<scio:hasInjuryModel>
<scio:data/Contusion_3> ;
<scio:hasNNumber>
"12" ;
<scio:hasOrganismModel>
<scio:data/RatModel_6> ;
<scio:hasTreatmentType>
<scio:data/CompoundTreatment_518> .
Figure 6. RDF excerpt describing an experimental group instantiated as DefinedExperimentalGroup.
RDF code modelling an observation conducted during a particular temporal interval in
which a value of 12.5 was measured in a BBB test on the target group.
InvestigationMethod: A result is related to exactly one InvestigationMethod which
leads to an observation. Depending on the particular investigation method, different prop-
erties are used to specify its characteristics.
ExperimentalGroup: The ExperimentalGroup describes a set of animals (cf. Organis-
mModel) that were injured by a specific type of lesion (including sham injuries; cf. In-
juryType) and subsequently received a treatment (including sham treatments; cf. Treat-
ment). We distinguish two types of experimental groups: While a DefinedExperimental-
Group is explicitly defined by the author, an AnalyzedExperimentalGroup may refer to a
sub-group and/or pooling of experimental groups. This enables arbitrary aggregation of
groups for analysis. Thus, the ontology is not limited to compare only two groups (target
vs. control group), but an arbitrary number of groups being treated or injured differently.
This could be the case if the author clusters multiple experimental groups that received
the same substance but with different dosages. Figure 6 shows an example.
OrganismModel: The OrganismModel describes the animal model that was used in
the experiments together with its properties. An organism model is defined by its
species, gender, weight, and age. We distinguish between categorical ages, i.e., “adult”
or “young”, and non-categorical ages, e.g., “3 months”. The RDF code in Figure 7 de-
scribes a rat model consisting of male, adult rats of the subspecies SpragueDawleyRat
and weighing 312.5g (on average).
<scio:data/RatModel_6>
a <scio:RatModel> ;
<scio:hasAgeCategory>
<scio:Adult> ;
<scio:hasGender>
<scio:Male> ;
<scio:hasSpecies>
<scio:SpragueDawleyRat> ;
<scio:hasWeight>
"312.5 g" .
Figure 7. RDF excerpt describing an adult, male Sprague Dawley Rat model.
<scio:data/Contusion_3>
a <scio:Contusion> ;
<scio:hasInjuryDevice>
<scio:data/NYUImpactor_73> ;
<scio:hasInjuryLocation>
<scio:Thoracic> .
Figure 8. RDF excerpt describing a contusion applied using an NYU Impactor at thoracic level.
Injury: An Injury represents a type of injury that was applied to the animals in the
treatment group. A description of the Injury includes the device that was used to cause
the spinal cord injury, the area and the height (location) of the injury. Besides those
main properties, an injury type comprises information about pre- and post-medication,
anesthesia, and further animal care conditions such as housing, nutrition, and hydration,
which are all modelled using object properties. The RDF code in Figure 8, for instance,
describes a Contusion applied via an NYU Impactor at Thoracic level.
Treatment: A Treatment represents the application of a drug (in case of a Com-
poundTreatment), device or other therapeutic intervention (e.g., rehabilitative training)
at a particular location of the spinal cord, with a specific dosage or a specific intensity,
respectively. A treatment can be applied once, at intervals or for a specific duration. The
RDF code in Figure 9, for instance, represents a compound treatment that is delivered
intraperitoneally and has a specific Dosage. The SuppliedCompound stands for a com-
pound produced by a certain supplier.
2.3. Subclasses in SCIO
For each of the top level classes described above, a number of subclasses have been intro-
duced manually through observation in scientific publications: InvestigationMethod (88
subclasses), InjuryType (11), InjuryDevice (30), Anaesthetics & Medication (21), Ani-
malSpecies (17), Treatment (excl. CompoundTreatment; 17), CompoundTreatment (ap-
plied compounds; 84).
2.4. Alignment to other Ontologies
SCIO imports or is aligned with several ontologies:
<scio:data/CompoundTreatment_518>
a <scio:CompoundTreatment> ;
<scio:hasDeliveryMethod>
<scio:IntraperitonealDelivery> ;
<scio:hasDosage>
<scio:data/Dosage_31>;
<scio:hasSuppliedCompound>
<scio:data/SuppliedCompound_18> .
Figure 9. RDF excerpt describing a Treatment instance.
<scio:data/TemporalInterval_445>
a <scio:TemporalInterval> ;
<scio:hasTemporalDuration>
<scio:data/TemporalDuration_4>
<scio:hasEventAfter>
<scio:data/CompoundTreatment_429> ;
<scio:hasEventBefore>
<scio:data/Contusion_185> .
<scio:data/TemporalDuration_4>
a time:Duration ;
time:numericDuration
"1"^^xsd:decimal ;
time:#unitType
time:unitWeek .
Figure 10. RDF code showing how to model the time passed between injury and treatment in terms of the
duration of an intermediate interval.
Time Ontology: Modeling the temporal structure of events is a key component in cap-
turing the core parameters of a pre-clinical trial. Thus, the entities Injury, Treatment and
Observation are modelled in SCIO as perdurants or occurrents according to the W3C
Time Ontology6. They are modelled as subclasses of scio:Event, which is a sub-
class of time:TemporalEntity. The time passed between an injury and treatment
is modelled via an interval that immediately succeeds the injury interval and precedes
the treatment interval, as shown in the RDF code in Figure 10. This example models the
situation that a treatment is applied one week after injury in terms of an intermediate
interval with the respective duration.
QUDT Ontology: We reuse the QUDT Ontology7 to model quantities and their units. In
particular, the following classes are modelled as subclasses of qudt:Quantity: Tem-
perature, Force, ElectricFieldStrength, Duration, MeanValue, Dosage, Pressure, Longi-
tude, Weight, Depth, Thickness, MedianValue, Volume, DosageExtracorporal, Voltage,
DosageIntracorporal, NumericValue, Current, Distance, Age. The RDF code in Figure
11 shows how a dosage of 20,000 units per liter is modelled as an instance of Quantity.
6http://www.w3.org/2006/time
7http://data.qudt.org/qudt/owl/1.0.0/
<scio:data/Dosage_31>
a qudt:Quantity ;
qudt:quantityValue [
qudt:unit qudt#InternationalUnitPerLiter> ;
qudt:numericValue> "20,000" ].
Figure 11. RDF code showing how a dosage as consisting of a unit and a value is modelled as an instance of
Quantity.
?Result <rdf:type> <scio:Result>.
?Result <scio:hasTargetGroup> ?TargetExperimentalGroup.
?TargetExperimentalGroup <scio:hasOrganismModel> ?OrganismModel.
?OrganismModel <scio:hasGender> ?Gender.
?OrganismModel <scio:hasGender> <scio:Male>.
{?OrganismModel <rdf:type> <scio:RatModel>. }
UNION
{?OrganismModel <rdf:type> <scio:MouseModel>. }.
?TargetExperimentalGroup <scio:hasTreatmentType> ?TreatmentTypes.
?TreatmentTypes <scio:hasSuppliedCompound> ?SuppliedCompound.
?SuppliedCompound <scio:hasCompound> ?Compound.
?SuppliedCompound <scio:hasCompound> <scio:Erythropoietin>.
Figure 12. SPARQL query generated by SCIExplorer for answering competency question (5) in Section 2.1.
3. Proof of Concept
We have implemented the web application SCIExplorer8 that enables domain experts to
explore the available evidence and to answer questions regarding the positive or negative
effect of a treatment under different side conditions formalized as filters based on SCIO
concepts [5]. The data underlying SCIExplorer was manually gathered by domain ex-
perts9 in a process of analyzing 140 scientific articles and entering their key parameters
into a spreadsheet which was then automatically transferred to RDF using SCIO. When
accessing the web application, users can enter a potential therapy and get an overview
of different diagrams plotting the ratio of positive to negative results on a therapy over
animal models.
As a proof of concept, we demonstrate how competency question (5) as introduced
in Section 2.1 can be answered using SCIExplorer: Figure 12 shows the SPARQL query
that has been automatically generated from the appropriate filter settings10. The resulting
RDF triples matching this query can be retrieved from http://psink.techfak.
uni-bielefeld.de/scio/examples/CQ5-result.rdf.
Analogously, competency questions (1)–(3) can be answered via SCIExplorer by
accessing the relevant information for specific treatments11. For competency question
8http://psink.techfak.uni-bielefeld.de/SCIExplorer/
9In the PSINK project, we are developing a semi-automatic workflow for robust, large-scale knowledge
extraction using text mining and information extraction methods.
10https://tinyurl.com/SCIExplorer-settings
11The view for Estrogen treatments, e.g., can be found at https://tinyurl.com/scioestrogen
treatment.
(4), the information can be retrieved by setting a filter on InjuryType→InjuryVertebral-
Location to Cervical and Thoracic.
4. Related Work
Several ontologies have been proposed to formally capture the structure and outcomes of
pre-clinical or clinical studies. A prominent example for an ontology for clinical stud-
ies is the PICO ontology, developed by the Cochrane Foundation [7]. The main entity
in the PICO ontology is a PICO class to represent the main aspects of a clinical study:
Patient, Population, Problem, Intervention, Comparison and Outcome. PICO proposes a
star-based modelling scheme in which a number of object properties are connected to an
instance of the PICO class, in particular: population, excludedPopulation, intervention-
Group and outcomeGroup. Populations are described via age (with class Age as range),
condition (with class Condition as range) and sex (with class Sex as range) properties. An
OutcomeGroup (range of outcomeGroup) represents a group of outcomes. Correspond-
ing classes in PICO and SCIO are Population and AnimalModel, as well as Outcome and
Result. However, the modelling of the actual experimental result is much more detailed
in SCIO than in PICO. Rather than modeling the Result as an atomic entity, SCIO cap-
tures the different experimental groups, the instrument and test applied to measure the
outcome, the exact location of application and injury, the time of application, the result
of statistical tests applied, etc. The modelling of the structure of a study is thus richer in
the case of SCIO .
Khoo et al. developed an ontology to represent disease treatment information in
medical abstracts [11]. In their modelling, an instance of a Disease-Treatment class is
related to a Condition, a Treatment, a Disease, an Effect and Evidence for this effect.
The Disease-Treatment class is thus equivalent to the class PICO in the PICO ontology.
However, the modelling is more fine-grained than in PICO with administration schemes
that include frequency and duration for Treatments. Measurements are modeled similarly
to SCIO, whereas different types of effects are distinguished: disease effects, side effects
and patient effects. The Modality class corresponds to the Judgement class in SCIO, rep-
resenting the truth value of the occurrence of the effect. The Condition class has sub-
classes for PatientCondition, TreatmentCondition and DiseaseCondition. The Evidence
class represents statistical evidence including sampling information as well as informa-
tion about the experimental subjects. In contrast to SCIO, there is no detailed vocabulary
to capture the statistical information in detail (e.g., which statistical test, which p-value)
nor vocabulary to capture details of the experimental subjects.
Our work is also related to the efforts of developing an ontology of clinical research,
viz., the OCRe ontology [9,10]. Significant differences to SCIO are: (i) OCRe was de-
signed to represent human studies; (ii) its focus is on the representation of the study pro-
tocol, i.e., the abstract representation of the scientific design of a clinical study. Repre-
senting actual results and observations produced in a study is out of the scope of OCRe.
Regarding pre-clinical studies, most closely related to our work is the RegenBase
project [6], which also develops an ontology and knowledge base of SCI biology. The
main publication of the project does not fully explain the main design choices. We there-
PREFIX hyque: <http://semanticscience.org/ontology/hyque.owl#>
PREFIX regenbase: <http://regenbase.org/ontology#>
PREFIX sio: <http://semanticscience.org/resource/>
# return distinct agent PubChem compound identifiers
SELECT DISTINCT ?pubchem_id
WHERE {
# retrieve agent, target, and effect
?event hyque:HYPOTHESIS_0000015 ?agent .
?agent sio:SIO_000671 ?pubchem_id .
?event hyque:HYPOTHESIS_0000016 ?target .
# filter agent to be a small molecule
?agent rdf:type regenbase:RB_0000125 .
?agent ?effect ?target .
?effect rdfs:label ?effect_label .
# filter effect to be ’increase’
FILTER(?effect_label = "increase") .
# filter target to be an outcome measure or any subclass
?target rdf:type/rdfs:subClassOf* regenbase:RB_0008016 .
}
Figure 13. Example query for answering a competency question using the RegenBase Ontology [6]
fore compare our project to their online version of the ontology12 based on our compe-
tency questions.
On the website of RegenBase, the authors provide the example query shown in Fig-
ure 13 that can be evaluated on the RegenBase SPARQL endpoint, answering the ques-
tion: What perturbagens have been observed to improve behavioral outcomes following
injury? As shown in Figure 13, RegenBase represents hypotheses using HYQUE [8], a
system and vocabulary supporting hypothesis formulation and evaluation. In the above
query, the variable ?agent ranges over possible substances and is constrained to a small
molecule (regenbase:RB_0008016). The variable ?target ranges over entities
defined in the RegenBase ontology and can be bound to different biological processes
such as gene expression, a phosphorylation, a behavioural test. The ?target variable
is constrained to be of type ‘behavioural assessment’ (regenbase:RB_0008016).
The relation between an ?agent and a ?target is modelled using a property in-
stance to which information characterizing the relation can be added. The fact that the
?agent improves or increases the ?target biological process is expressed via an
rdfs:label on the individual property and is constrained to the string ‘increase’.
Thus, neither is the relation between an ?agent and a ?target modelled from an
ontological point of view, nor is there an ontologically appropriate way to represent im-
provements in RegenBase. According to these design choices, it is presumable that the
potential future functions of RegenBase do not include modelling of more complex ques-
tions as targeted by SCIO, e.g., regarding the effects of dosage, time point of application,
or delivery method. Overall, RegenBase seems to be designed for different goals and
might complement SCIO with respect to a mechanistic understanding of molecular path-
ways underlying study results in the future. Questions focussing on study design choices
12https://bioportal.bioontology.org/ontologies/RB
in pre-clinical experiments, however, can so far only be addressed by SCIO, since this is
the only available ontology modelling the central relations in this respect.
5. Conclusion
This paper discusses SCIO, a novel ontology to formalize pre-clinical studies in the
spinal cord injury domain. Its core structure is driven by design decisions to enable fine-
grained representations of the specific characteristics of experiments in the domain.
The web application SCIExplorer serves as a proof of concept. It structures the pre-
clinical evidence which is available and supports domain experts in the exploration of this
information. Future work will focus on developing an information extraction pipeline in
which the ontology represents a core element.
SCIO is available for download at http://psink.de/scio/.
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